Production (Stage)
Merck KGaA
MKGAF
$129.80
-$1.65-1.26%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.03% | 2.67% | 2.82% | -0.18% | -2.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.03% | 2.67% | 2.82% | -0.18% | -2.08% |
| Cost of Revenue | -1.96% | -1.20% | -0.86% | -2.04% | 8.31% |
| Gross Profit | 1.32% | 5.68% | 5.47% | 1.07% | -8.25% |
| SG&A Expenses | 0.22% | 10.61% | 0.58% | -1.25% | -2.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 49.14% | -252.18% | 280.46% | 182.13% | -64.27% |
| Total Operating Expenses | -1.12% | -8.89% | 0.52% | 4.06% | -0.41% |
| Operating Income | 4.85% | 75.81% | 12.61% | -19.16% | -8.94% |
| Income Before Tax | 3.08% | 25.12% | 12.31% | -13.27% | -10.16% |
| Income Tax Expenses | 5.66% | 161.55% | 18.44% | -5.32% | -4.95% |
| Earnings from Continuing Operations | 2.35% | 12.82% | 10.68% | -15.38% | -11.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 41.84% | -48.52% | -51.51% | 165.92% | -26.54% |
| Net Income | 2.67% | 12.70% | 10.57% | -14.74% | -11.74% |
| EBIT | 4.85% | 75.81% | 12.61% | -19.16% | -8.94% |
| EBITDA | 3.59% | 50.46% | 10.05% | -13.10% | -5.97% |
| EPS Basic | 2.40% | 12.69% | 10.51% | -14.55% | -11.50% |
| Normalized Basic EPS | 3.21% | 57.34% | 12.11% | -12.25% | -10.15% |
| EPS Diluted | 2.40% | 13.14% | 10.51% | -14.55% | -11.50% |
| Normalized Diluted EPS | 3.21% | 57.34% | 12.11% | -12.25% | -10.15% |
| Average Basic Shares Outstanding | 0.27% | 0.00% | 0.06% | -0.23% | -0.28% |
| Average Diluted Shares Outstanding | 0.27% | 0.00% | 0.06% | -0.23% | -0.28% |
| Dividend Per Share | -- | -0.99% | -- | -- | -- |
| Payout Ratio | -0.16% | -- | -- | 0.07% | -0.34% |